Sunday, October 21, 2018 1:01:21 PM
Press Release | 10/20/2018
On October 19, 2018, Amarantus Biocience Holdings, Inc. (OTCPK: AMBS, AMBS, or the Company) entered into a term sheet with institutional investors (the Investors) to raise $700,000 in senior secured convertible debt (the Notes) for the primary purpose of supporting a joint venture (the JV) proposal submitted by the Company to MER Telemanagement Solutions (NASDAQ:MTSL, MTSL). The Notes would be secured by 1,098,000 shares of MTSL that would be owned by the Company in the event the JV offer presented by the Company to MTSL is accepted.
https://www.otcmarkets.com/stock/AMBS/news
FEATURED CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • Oct 8, 2024 8:00 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM